BioDelivery Sciences Int'l (Nasdaq: BDSI) 58.4% HIGHER; Announced statistically significant results with BEMA(TM) Fentanyl in cancer patients with breakthrough pain ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE